Health data partnerships

De-identified Health Data for the Betterment of Health

OPES Health Systems invites hospitals, clinics, pharmacies, pharmaceutical companies, laboratories and other health institutions to discuss licensing de-identified data to OPES for research and health-system improvement projects.

Participate

Propose a data partnership

Tell us about your institution and the research question you have in mind. This initial enquiry transfers no data and does not constitute a licence agreement.

Do not send patient records, identifiers, data extracts, samples or confidential information.

Partnering to make health research more useful

We want to hear from institutions that generate or hold health data and are considering authorising its use for a defined, governed purpose that can contribute to care or public health.

  • Hospitals and teaching hospitals
  • Clinics and other care providers
  • Pharmacies and pharmacy networks
  • Pharmaceutical companies and manufacturers
  • Diagnostic and research laboratories
  • Public health programmes and research institutions

A clear purpose before any access

The examples below are topics for discussion, not a claim that these datasets are available. Purpose, source, fields, time period and outputs are agreed with each institution.

Care pathways, referrals and service utilisation

Study aggregate patterns or operational questions within an agreed scope and time period.

Medicine dispensing patterns and availability

Study aggregate patterns or operational questions within an agreed scope and time period.

Laboratory operations and diagnostic pathways

Study aggregate patterns or operational questions within an agreed scope and time period.

Medical device use and maintenance needs

Study aggregate patterns or operational questions within an agreed scope and time period.

Health data quality and completeness

Study aggregate patterns or operational questions within an agreed scope and time period.

Applied research and technology evaluation

Study aggregate patterns or operational questions within an agreed scope and time period.

Authority and safeguards come first

A licence does not replace a lawful basis, institutional approvals, confidentiality obligations or ethics review that may apply. Removing direct identifiers alone does not eliminate all risk.

Governance and authority

Confirm the institution’s rights, lawful basis, approvals and, where required, ethics review before any use.

De-identification and risk

Define and assess the de-identification methods and residual re-identification risk for the data and its context.

Purpose limitation

Document a specific purpose, authorised users, retention period, restrictions and deletion requirements.

Security and accountability

Set access controls, security measures, incident duties and a contractual prohibition on re-identification.

Review for each jurisdiction. Projects involving Cameroon must be assessed against Law No. 2024/017 on personal data protection and applicable sector rules. Projects elsewhere are reviewed under local law. The source institution must confirm it can authorise the proposed sharing and use.

From an initial conversation to a governed agreement

01

Initial discussion

Describe the institution and high-level need without sending any data.

02

Feasibility and governance

Review rights, purpose, approvals, risks and operational capability.

03

Protocol and licence

Agree fields, access, responsibilities, duration, any fees and restrictions.

04

Controlled transfer or analysis

Start only after required approvals, contracts and security controls are in place.

Before you get in touch

What does “de-identified” mean?

Direct identifiers are removed or transformed and residual risk is assessed. The label alone does not establish that a dataset is anonymous or risk-free.

Does OPES accept identifiable patient records?

Do not send patient records or identifiers through the website form or by email. Any source or transfer requires prior review of authority, purpose, safeguards and contractual terms.

Who can propose a partnership?

Hospitals, clinics, pharmacies, pharmaceutical companies, laboratories, public health programmes, universities and research institutions can submit a high-level proposal.

Are a licence or datasets already available?

No. This page invites proposals for discussion. Each project, dataset, approval, availability, licence and safeguard must be reviewed and agreed separately.

Does your institution hold data that could support health research?

Tell us about your organisation and proposal at a high level. Do not send records, patient identifiers, data samples or sensitive information through the form or by email.

Start a conversation